Max Dawson
Listed on 1 Form D filing across 1+ issuer
· Executive Officer
Associated issuers
- Rinascera Therapeutics, Inc. CIK 2090779 · MA
Filings (1)
-
Rinascera Therapeutics, Inc.D · 2025-10-08 · MA · Biotechnology$2.5Mview →